Clorox (CLX) Trims FY18 View Despite Q1 Earnings & Sales Beat
The Clorox Company CLX posted robust first-quarter fiscal 2018 results, wherein both top and bottom line topped estimates and grew year over year. Notably, earnings marked the fourth straight quarterly beat, while sales surpassed estimates for the second consecutive quarter.
Quarterly earnings from continuing operations of $1.46 per share jumped 7% year over year and surpassed the Zacks Consensus Estimate of $1.41. Results primarily gained from solid sales and gross margin expansion.
Net sales of $1,500 million advanced nearly 4% year over year, also coming ahead of the Zacks Consensus Estimate of $1,478 million. The top line beat was driven by growth across the United Sates and International businesses, as well as 4% rise in volumes. Growth at the International business was backed by increased pricing, offset by unfavorable mix.
Clorox’s gross margin expanded 50 basis points (bps) to 44.9% in the quarter, thanks to efficient cost savings and improved pricing in the International business, somewhat offset by increase in manufacturing and logistics expenses as well as greater commodity expenses.
Revenue by Segment
Sales in the Cleaning segment improved 5% to $559 million, mainly driven by strength in Home Care with higher shipments for several Clorox branded products, particularly Clorox disinfecting wipes, along with Scentiva wipes and sprays introduced in January 2017.
Household sales grew 5% to $441 million aided by volume growth across all businesses, particularly Cat Litter. Results also benefited from increased merchandising activity for product innovation in Bags and Wraps and greater shipments of Glad premium trash bags.
Sales at the Lifestyle segment rose 4% to $246 million driven by strength in Burt’s Bees Natural Personal Care, which witnessed double-digit volume growth. Top-line growth also reflected the benefits of improved sales in Dressings and Sauces, supported by increased merchandising for bottled Hidden Valley ranch products.
In the International business segment, sales grew 1% to $254 million driven by improved pricing, partly negated by volume declines, particularly in Argentina.
Clorox ended the quarter with cash and cash equivalents of $468 million, and long-term debt of $1,787 million. In first-quarter fiscal 2018, the company generated $257 million of net cash from continuing operations.
Following the first-quarter results, the company slashed guidance for fiscal 2018 to include the hurricane-related impacts and the divestiture of the Aplicare business in August 2017.
The company now expects fiscal 2018 sales growth in a range of 1-3%, compared with the previous guidance of 2-4% growth. The lowered guidance reflects a slightly less than 1 percentage point reduction in the fiscal year related to the Aplicare divestiture.
Gross margin is now estimated to be down slightly, versus the earlier guidance of expanding slightly. The recent guidance reflects significant cost pressures due to the recent hurricanes, particularly in the second and third quarters.
Driven by an anticipated 10 cent impact from hurricanes, the company now envisions fiscal 2018 earnings from continuing operations to range from $5.47-$5.67 per share, reflecting a 5 cent decline from the previous guidance of $5.52-$5.72 per share. However, the company anticipates the impacts of hurricanes to be partly mitigated by continued strength in its underlying business performance.
Clorox currently carries a Zacks Rank #4 (Sell). While shares of the company have increased 4.4% year to date, Clorox underperformed the industry’s growth of 13.6%.
Interested in Consumer Staples Space? Check these 3 Hot Picks
Better-ranked stocks in the consumer staples sector include Unilever Plc UL, Snyder’s-Lance, Inc. LNCE and McCormick & Company, Incorporated MKC, all carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Unilever, with long-term EPS growth rate of 9.3%, has increased 36.4% year to date.
Snyder’s-Lance has increased 5.7% in the last three months. Moreover, the company has to its credit a spectacular earnings history as it delivered an average positive earnings surprise of 2.1% in the trailing four quarters.
McCormick & Company, with long-term EPS growth rate of 9.4%, has grown 2.5% in last three months.
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don’t buy now, you may kick yourself in 2020.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Unilever PLC (UL): Free Stock Analysis Report
McCormick & Company, Incorporated (MKC): Free Stock Analysis Report
Snyder’s-Lance, Inc. (LNCE): Free Stock Analysis Report
Clorox Company (The) (CLX): Free Stock Analysis Report
To read this article on Zacks.com click here.